SeekingAlpha · Jul 2, 2026
InnovAge: A Real Turnaround, But The Stock Now Trades Above Every Analyst Target
InnovAge's turnaround boosts adjusted EBITDA and guidance, but shares hit ATH above targets. Click for more on INNV stock.
NASDAQ · INNV
InnovAge Holding Corp.
Healthcare · Medical - Care Facilities
$10.94
Down-$0.16 (-1.44%)
Updated Aug 20, 2026, 5:51 AM
SID Score
6.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 724.13M
- P/E ratio
- -41.77
- Dividend yield
- 0.00%
- 52-week range
- $3.26 – $12.64
- Volume
- 158.04K
- Avg. volume
- 130.78K
Price performance
INNV price history
1M range · 0 trading sessions · Daily adjusted prices
INNV does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
Latest INNV news
The latest Smart Investors Daily articles mentioning INNV.
Stock researchCompany · Overview
INNV research
Overview
Company profile and research snapshot.
Company profile
InnovAge Holding Corp is a healthcare delivery platform comprising multiple participants focused on providing all-inclusive, capitated care to high-cost seniors, many of whom are dual-eligible. Its programs are designed to address two of the pressing challenges facing the U.S. healthcare industry: rising costs and poor outcomes. The purpose of the participant-centered care delivery approach is to improve the quality of care participants receive, while keeping them in their homes for as long as possible and reducing the overutilization of high-cost care settings, such as hospitals and nursing homes. The company manages its business as one reportable segment, PACE.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $6.80
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Feb 23, 2026 | JP Morgan | Underweight | — |
| Dec 17, 2024 | JP Morgan | Underweight | — |
| Oct 11, 2024 | Keybanc | Sector Weight | — |
| Mar 13, 2024 | JP Morgan | Neutral | — |
| Feb 8, 2024 | Goldman Sachs | Neutral | — |
News briefing
No generated briefing is available yet.
Benzinga · Jun 10, 2026
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Yahoo · Mar 31, 2026
Evaluating Acadia Healthcare's Outlook: Hold for Now or Fold?
ACHC rides on strong demand and expansion gains, but premium valuation, rising costs, and weak efficiency raise caution for investors weighing next moves.
Yahoo · Mar 27, 2026
Pediatrix Ties Up to Provide Better Maternal Care in Tennessee
MD expands maternal care in Tennessee through a new partnership, boosts high-risk pregnancy services and aims for immediate earnings accretion.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
